Login

Join for Free!
17043 members
table of contents table of contents

A fully automated assay to determine the enzymology of drug oxidation by …


Biology Articles » Biochemistry » Enzymology » Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s » Tables

Tables
- Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s

..................................................

TABLE 1
CYP isoform characterization of individual HLM pools

 

Isoform Probe Batch 1 Batch 2 Batch 3
pmol/min/mg
P450 content CO difference spectrum 320a 280a 430a
P450 reductase Cytochrome c reduction 69000 84000 75000
CYP 7-Ethoxycoumarin O-demethylation 255 210 240
CYP1A2 Phenacetin O-dethylation 366 310 193
CYP2A6 Coumarin 7-hydroxylation 17200 81900 58600
CYP2E1 Chlorzoxazone 6-hydroxyline 1010 1911 1441
CYP2C Mephenytoin 4-hydroxylation 27 233 11
CYP2D6 Dextromethorphan O-demethylation 200 84 106
CYP3A Testosterone 6beta-hydroxylation 2600 1500 1900
CYP4A Lauric acid 11-hydroxylation 1000 1600 1600
a  Picomoles of CYP per milligram of microsomal protein.

..................................................

TABLE 2
Estimated levels of the five major isoforms in HLM pools

Mean total level = 320 pmol of CYP · mg-1 of microsomal protein.

Isoform Mean References
%
CYP1A2 13 Shimada et al. (1994), Guengerich and Turvy (1991), Belloc et al. (1996)
CYP2C9 20 Shimada et al. (1994), Becquemont et al. (1998), Wester et al. (2000), Inoue et al. (1997), Lasker et al. (1998)
CYP2C19 4 Wester et al. (2000), Inoue et al. (1997), Lasker et al. (1998)
CYP2D6 2 Shimada et al. (1994), Becquemont et al. (1998), Imaoka et al. (1996)
CYP3A4 30 Shimada et al. (1994), Belloc et al. (1996), Becquemont et al. (1998)

..................................................

TABLE 3
CLint of marker substrates in different HLM pools and literature values

 

Compound CLint References
Batch 1 Batch 2 Batch 3 Mean Literature
µl · min-1mg-1
Tolbutamide 0.7a 0.5-2.5; 1 ± 0.2 Iwatsubo et al. (1997), Doecke et al. (1991), Back et al. (1988), Bourrie et al. (1996), Obach (1999)
Diazepam 3  ± 1 2 2 3  ± 1 2.6  ± 0.8 Obach (1999)
Metoprolol 7  ± 1 5 5 6  ± 1 14, 19 Mautz et al. (1995)
Ibuprofen 14 5 5 8  ± 2 9.6  ± 1.1 Obach (1999)
Propranolol 16  ± 3 16 15 15  ± 0 11-60 Lave et al. (1997), Obach (1997), Otton et al. (1990)
Dextromethorphan 29  ± 3 30 33 29  ± 3  25-103 Kerry et al. (1994), Broly et al. (1990)
Omeprazole 43  ± 7 11 15 34  ± 14 18, 26 Andersson et al. (1993), Kobayashi et al. (1994)
Diltiazem 56  ± 7 22 22 45  ± 16 17  ± 2 Obach (1999)
Testosterone 81  ± 12 23 35 60  ± 18
Verapamil 380  ± 44 111 114 256  ± 100 139  ± 3 Obach (1999)
a  Determined from Vmax/Km. Where determined, results are presented as mean ± S.D.

..................................................

TABLE 4
Determination of CYP Clint of individual human CYPs to oxidative metabolism for marker substrates

 

Compound CLint
CYP1A2 CYP2C9 CYP2C19 CYP2D6 CYP3A4
µl · min-1pmol-1
Tolbutamide N.D.a 0.014b 0.03  ± 0.01 N.D. N.D.
Diazepam N.D. N.D. 0.17  ± 0.05 N.D. N.D.
Metoprolol N.D. N.D. N.D. 1.03  ± 0.07 N.D.
Ibuprofen N.D. 0.29 ± 0.09 0.17  ± 0.01 N.D. N.D.
Propranolol 0.34 ± 0.03 N.D. 0.66  ± 0.06 5.07  ± 2.80 N.D.
Dextromethorphan N.D. N.D. 0.16  ± 0.10 1.97  ± 0.24 N.D.
Omeprazole N.D. N.D. 6.95  ± 1.93 N.D. 0.44  ± 0.06
Diltiazem N.D. N.D. 0.30  ± 0.04 N.D. 0.58  ± 0.04
Testosterone N.D. N.D. N.D. N.D. 0.42  ± 0.03
Verapamil N.D. N.D. N.D. N.D. 1.19  ± 0.12
a  N.D., not detectable (-1 · pmol-1).
b  Determined from Vmax/Km. Mean ± S.D. for n = 3 separate experiments.

..................................................

TABLE 5
Mean percentage contribution of individual CYPs to oxidative metabolism

 

Compound CYP1A2 CYP2C9 CYP2C19 CYP2D6 CYP3A4 Literature
%
Tolbutamide 70 30 2C
Diazepam 100 2C19>3A
Metoprolol 100 2D6
Ibuprofen 90 10 2C9
Propranolol 26 15 59 2D6, 1A2, 2C19
Dextromethorphan 14 86 2D6>3A
Omeprazole 68 32 2C193A
Diltiazem 7 93 3A
Testosterone 100 3A
Verapamil 100 3A

..................................................

TABLE 6
Determination of CYP Clint for marker and AR-C compounds

 

Compound CLint
HLM CYP
µl · min-1mg-1
Tolbutamide 0.7a 1.3a
Diazepam 3  ± 1 2  ± 1
Metoprolol 6  ± 1 7  ± 0
Ibuprofen 8  ± 2 20  ± 5
Propranolol 15  ± 0 55  ± 15
Dextromethorphan 29  ± 3 14  ± 1
Omeprazole 34  ± 14 131  ± 25
Diltiazem 45  ± 16 60  ± 3
Testosterone 60  ± 18 40  ± 3
Verapamil 256  ± 100 114  ± 11
a  Determined from Vmax/Km. Mean ± S.D.

..................................................


rating: 0.00 from 0 votes | updated on: 18 May 2007 | views: 334 |

Rate article:







excellent!bad…